Race Adjustment of Pulmonary Function Tests in the Diagnosis and Management of COPD: A Scoping Review
Sean Davidson,Muhammed Idris,Christopher Awad,Marshaleen Henriques King,Gloria E Westney,Mario Ponce,Anny Rodriguez,Kim Lipsey,Eric Flenaugh,Marilyn Foreman
DOI: https://doi.org/10.2147/copd.s430249
2024-04-30
International Journal of COPD
Abstract:Sean Richard Davidson, 1 Muhammed Y Idris, 2, 3 Christopher S Awad, 2 Marshaleen Henriques King, 1 Gloria E Westney, 1 Mario Ponce, 1 Anny D Rodriguez, 2 Kim L Lipsey, 4 Eric L Flenaugh, 1 Marilyn G Foreman 1, 3 1 Pulmonary and Critical Care Medicine Division, Department of Medicine, Morehouse School of Medicine, Atlanta, GA, USA; 2 Clinical Research Center, Morehouse School of Medicine, Atlanta, GA, USA; 3 Center of Excellence for the Validation of Digital Health Technologies and Clinical Algorithms, Morehouse School of Medicine, Atlanta, GA, USA; 4 Bernard Becker Medical Library, Washington University in St. Louis, St. Louis, MO, USA Correspondence: Marilyn G Foreman, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA, 30310, USA, Tel +1 404 616 4658, Fax +1 404 756 1328, Email Aim: Increasing evidence suggests that the inclusion of self-identified race in clinical decision algorithms may perpetuate longstanding inequities. Until recently, most pulmonary function tests utilized separate reference equations that are race/ethnicity based. Purpose: We assess the magnitude and scope of the available literature on the negative impact of race-based pulmonary function prediction equations on relevant outcomes in African Americans with COPD. Methods: We performed a scoping review utilizing an English language search on PubMed/Medline, Embase, Scopus, and Web of Science in September 2022 and updated it in December 2023. We searched for publications regarding the effect of race-specific vs race-neutral, race-free, or race-reversed lung function testing algorithms on the diagnosis of COPD and COPD-related physiologic and functional measures. Joanna Briggs Institute (JBI) guidelines were utilized for this scoping review. Eligibility criteria: The search was restricted to adults with COPD. We excluded publications on other lung disorders, non-English language publications, or studies that did not include African Americans. The search identified publications. Ultimately, six peer-reviewed publications and four conference abstracts were selected for this review. Results: Removal of race from lung function prediction equations often had opposite effects in African Americans and Whites, specifically regarding the severity of lung function impairment. Symptoms and objective findings were better aligned when race-specific reference values were not used. Race-neutral prediction algorithms uniformly resulted in reclassifying severity in the African Americans studied. Conclusion: The limited literature does not support the use of race-based lung function prediction equations. However, this assertion does not provide guidance for every specific clinical situation. For African Americans with COPD, the use of race-based prediction equations appears to fall short in enhancing diagnostic accuracy, classifying severity of impairment, or predicting subsequent clinical events. We do not have information comparing race-neutral vs race-based algorithms on prediction of progression of COPD. We conclude that the elimination of race-based reference values potentially reduces underestimation of disease severity in African Americans with COPD. Keywords: lung function tests, lung function prediction equations, African Americans Globally, nearly 600 million individuals aged ≥ 25 years are projected to have chronic obstructive pulmonary disease (COPD) by the year 2050, an increase of 23%. 1 COPD, one of the top three leading causes of death worldwide, is commonly manifested by a triad of persistent respiratory symptoms: dyspnea, cough/wheeze, and sputum production. 2 African American adults are known to develop COPD at younger ages, with less intensive smoking histories, have a higher risk for severe exacerbations, and a reduced quality of life. 3,4 The excess morbidity and mortality experienced by African Americans with COPD may result from reduced lung growth from early life factors, the high prevalence of asthma, nutritional factors, environmental and other exposures resulting from structural racism. 4–6 Race-based algorithms may have been altruistically designed to enhance fairness to specific groups, but race is a social construct that is not a proxy for genetics, may be fluid and context dependent, and may reflect social and environmental conditions rather than true causality. 7 Despite high risk for poor outcomes, several race-based clinical treatment algorithms have failed to help racial and ethnic minorities who are often disproportionately affected by certain diseases, leading to lower organ transplant rates, -Abstract Truncated-
respiratory system